Grown Rogue International (GRUSF) Free Cash Flow (2013 - 2026)
Grown Rogue International's (GRUSF) quarterly Free Cash Flow came in at $17110.0 in Q1 2026, up 102.57% year-on-year from $8446.6 in Q1 2025, and up 100.0% quarter-over-quarter from -$1287.2 billion in Q4 2025.
Grown Rogue International (GRUSF) Free Cash Flow (2013 - 2026) Analysis & Trends
Grown Rogue International's Free Cash Flow history runs 14 years deep, the most recent figure standing at $17110.0 for Q1 2026.
- On a quarterly basis, Free Cash Flow rose 102.57% year-over-year to $17110.0 in Q1 2026; TTM through Mar 2026 was -$230.7 billion, a 6532409.78% decrease from a year earlier, with the FY2025 full-year figure at -$1.1 million, down 120.93% from the prior year.
- Free Cash Flow rose to $17110.0 in Q1 2026 per GRUSF's latest filing, from -$1287.2 billion in the prior quarter.
- Across five years, Free Cash Flow topped out at $1056.5 billion in Q3 2025 and bottomed at -$1287.2 billion in Q4 2025.
- The 5-year median for Free Cash Flow is $884727.8 (2024), against an average of -$16.5 billion.
- Biggest YoY gain for Free Cash Flow was 86248785.29% in 2025; the steepest drop was 85066906.27% in 2025.
- Year by year, Free Cash Flow stood at $634698.1 in 2022, then tumbled by 119.96% to -$126690.0 in 2023, then surged by 1294.41% to $1.5 million in 2024, then plunged by 85066906.27% to -$1287.2 billion in 2025, then surged by 100.0% to $17110.0 in 2026.
- Per Business Quant, the three latest GRUSF Free Cash Flow figures stand at $17110.0 (Q1 2026), -$1287.2 billion (Q4 2025), and $1056.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | 17,110.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,110.00 |
| Mar 31, 2026 | 17,110.00 |
| Dec 31, 2025 | -1,287.22 Bn |
| Dec 31, 2025 | -1,287.22 Bn |
| Sep 30, 2025 | 1,056.50 Bn |
| Sep 30, 2025 | 1,056.50 Bn |
| Jun 30, 2025 | 773,726.00 |
| Jun 30, 2025 | 773,726.00 |
| Mar 31, 2025 | -666,732.33 |
| Mar 31, 2025 | -666,732.33 |
| Dec 31, 2024 | 1.51 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 995,729.65 |
| Mar 31, 2024 | 995,729.65 |
| Dec 31, 2023 | -126,690.00 |
| Dec 31, 2023 | -126,690.00 |